# Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1

> **NCT06381102** · NA · COMPLETED · sponsor: **University of Miami** · enrollment: 31 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** transcutaneous auricular vagus nerve stimulation 30/30
- **DEVICE:** transcutaneous auricular vagus nerve stimulation 10/10

## Key facts

- **NCT ID:** NCT06381102
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-04-13
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-10-01
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2025-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06381102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06381102, "Transcutaneous Vagus Nerve Stimulation (taVNS) Dosage Study 1". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06381102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*